|
1
|
Bentata Y, Haddiya I, Latrech H, Serraj K
and Abouqal R: Progression of diabetic nephropathy, risk of
end-stage renal disease and mortality in patients with type-1
diabetes. Saudi J Kidney Dis Transpl. 24:392–402. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu Y: Cellular and molecular mechanisms
of renal fibrosis. Nat Rev Nephrol. 7:684–696. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ding Y and Choi ME: Autophagy in diabetic
nephropathy. J Endocrinol. 224:R15–R30. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Choi AM, Ryter SW and Levine B:
Autophagyin human health and disease. N Engl J Med. 368:651–662.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Velentzas PD, Velentzas AD, Mpakou VE,
Antonelou MH, Margaritis LH, Papassideri IS and Stravopodis DJ:
Detrimental effects of proteasome inhibition activity in Drosophila
melanogaster: Implication of ER stress, autophagy, and apoptosis.
Cell Biol Toxicol. 29:13–37. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim WY, Nam SA, Song HC, Ko JS, Park SH,
Kim HL, Choi EJ, Kim YS, Kim J and Kim YK: The role of autophagy in
unilateral ureteral obstruction rat model. Nephrology (Carlton).
17:148–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Otunctemur A, Ozbek E, Dursun M, Sahin S,
Besiroglu H, Ozsoy OD, Cekmen M, Somay A and Ozbay N: Protective
effect of hydrogen sulfide on gentamicin-induced renal injury. Ren
Fail. 36:925–931. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Han K, Zhou H and Pfeifer U: Inhibition
and restimulation by insulin of cellular autophagy in distal
tubular cells of the kidney in early diabetic rats. Kidney Blood
Press Res. 20:258–263. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li L, Zepeda-Orozco D, Black R and Lin F:
Autophagy is a component of epithelial cell fate in obstructive
uropathy. Am J Pathol. 176:1767–1778. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ding Y and Choi ME: Regulation of
autophagy by TGF-β: Emerging role in kidney fibrosis. Semin
Nephrol. 34:62–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Forbes MS, Thornhill BA, Minor JJ, Gordon
KA, Galarreta CI and Chevalier RL: Fight-or-flight: Murine
unilateral ureteral obstruction causes extensive proximal tubular
degeneration, collecting duct dilatation, and minimal fibrosis. Am
J Physiol Renal Physiol. 303:F120–F129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee HB, Yu MR, Yang Y, Jiang Z and Ha H:
Reactive oxygen species-regulated signaling pathways in diabetic
nephropathy. J Am Soc Nephro. 14 8 Suppl 3:S241–S245. 2003.
View Article : Google Scholar
|
|
13
|
Cuyàs E, Corominas-Faja B, Joven J and
Menendez JA: Cell cycle regulation by the nutrient-sensing
mammalian target of rapamycin (mTOR) pathway. Methods Mol Biol.
1170:113–144. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Heras-Sandoval D, Pérez-Rojas JM,
Hernández-Damián J and Pedraza-Chaverri J: The role of
PI3K/AKT/mTOR pathway in the modulation of autophagy and the
clearance of protein aggregates in neurodegeneration. Cell Signal.
26:2694–2701. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang C, Cao Y, Zhang Y, Li L, Xu M, Long
Y, Rong R and Zhu T: Cyclic helix B peptide inhibits ischemia
reperfusion-induced renal fibrosis via the PI3K/Akt/FoxO3a pathway.
J Transl Med. 13:3552015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou LN, Wang N, Dong Y, Zhang Y, Zou H,
Li Q, Shi Y, Chen L, Zhou W, Han C and Wang Y: Increased Expression
of p-Akt correlates with Chronic Allograft Nephropathy in Rat
Kidney Model. Cell Biochem Biophys. 71:1685–1693. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu N, Kong LS, Chen H, Li WD, Qian AM,
Wang XY, Du XL, Li CL, Yu XB and Li XQ: Autophagy protein 5
enhances the function of rat EPCs and promotes EPCs homing and
thrombus recanalization via activating AKT. Thromb Res.
136:642–651. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sharma K and Ziyadeh FN: Hyperglycemia and
diabetic kidney disease. The case for transforming growth
factor-beta as a key mediator. Diabetes. 44:1139–1146. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fornoni A, Ijaz A, Tejada T and Lenz O:
Role of inflammation in diabetic nephropathy. Curr Diabetes Rev.
4:10–17. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koesters R, Kaissling B, LeHir M, Picard
N, Theilig F, Gebhardt R, Glick AB, Hähnel B, Hosser H, Gröne HJ
and Kriz W: Tubular overexpression of transforming growth
factor-beta1 induces autophagy and fibrosis but not mesenchymal
transition of renal epithelial cells. Am J Pathol. 177:632–643.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ding Y, Kim JK, Kim SI, Na HJ, Jun SY, Lee
SJ and Choi ME: TGF-{beta}1 protects against mesangial cell
apoptosis via induction of autophagy. J Biol Chem. 285:37909–37919.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Haar L, Ren X, Liu Y, Koch SE, Goines J,
Tranter M, Engevik MA, Nieman M, Rubinstein J and Jones WK: Acute
consumption of a high-fat diet prior to ischemia-reperfusion
results in cardioprotection through NF-κB-dependent regulation of
autophagic pathways. Am J Physiol Heart Circ Physiol.
307:H1705–H1713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou X, Feng Y, Zhan Z and Chen J:
Hydrogen sulfide alleviates diabetic nephropathy in a
streptozotocin-induced diabetic rat model. J Biol Chem.
289:28827–28834. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aminzadeh MA and Vaziri ND: Downregulation
of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes
and capacity in chronic kidney disease. Nephrol Dial Transplant.
27:498–504. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang H, Xiao J, Kang B, Zhu X, Xin N and
Wang Z: PI3K/SGK1/GSK3β signaling pathway is involved in inhibition
of autophagy in neonatal rat cardiomyocytes exposed to
hypoxia/reoxygenation by hydrogen sulfide. Exp Cell Res.
345:134–140. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao DA, Liu J, Huang Q and Han ZM: Change
in plasma H2S level and therapeutic effect of H2S supplementation
in tubulointerstitial fibrosis among rats with unilateral ureteral
obstruction. Zhongguo Dang Dai Er Ke Za Zhi. 15:903–908.
2013.PubMed/NCBI
|
|
27
|
Cheng P, Wang F, Chen K, Shen M, Dai W, Xu
L, Zhang Y, Wang C, Li J, Yang J, et al: Hydrogen sulfide
ameliorates ischemia/reperfusion-induced hepatitis by inhibiting
apoptosis and autophagy pathways. Mediators Inflamm.
2014:9352512014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kimura H: Physiological role of hydrogen
sulfide and polysulfide in the central nervous system. Neurochem
Int. 63:492–497. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Szabó C: Hydrogen sulphide and its
therapeutic potential. Nat Rev Drug Discov. 6:917–935. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kundu S, Pushpakumar SB, Tyagi A, Coley D
and Sen U: Hydrogen sulfide deficiency and diabetic renal
remodeling: Role of matrix metalloproteinase-9. Am J Physiol
Endocrinol Metab. 304:E1365–E1378. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Santibañez JF, Quintanilla M and Bernabeu
C: TGF-β/TGF-β receptor system and its role in physiological and
pathological conditions. Clin Sci (Lond). 121:233–251. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yoon JJ, Lee YJ, Lee SM, Kang DG and Lee
HS: Oryeongsan suppressed high glucose-induced mesangial fibrosis.
BMC Complement Altern Med. 15:302015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jung KJ, Jang HS, Kim JI, Han SJ, Park JW
and Park KM: Involvement of hydrogen sulfide and homocysteine
transsulfuration pathway in the progression of kidney fibrosis
after ureteral obstruction. Biochim Biophys Acta. 1832:1989–1997.
2013. View Article : Google Scholar : PubMed/NCBI
|
